A selective growth-hormone secretagogue studied for its effects on growth hormone release.
Ipamorelin is a selective growth-hormone secretagogue, meaning it stimulates the release of growth hormone from the pituitary gland. It is noted in research for its relative selectivity compared to older secretagogues, with less effect on cortisol and other hormones in preclinical studies.
Ipamorelin is not FDA-approved for any human or veterinary use. It has not completed human clinical trials establishing safety or efficacy, and is classified as a research chemical intended solely for laboratory research.